Amanda D Castel1, Irene Kuo, Meriam Mikre, Toni Young, Meredith Haddix, Suparna Das, Geoffrey Maugham, Carol Reisen. 1. *Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC; †Community Education Group, Washington, DC; and ‡District of Columbia Department of Health, HIV/AIDS, Hepatitis, STD, TB Administration, Washington, DC.
Abstract
BACKGROUND: Improved detection and linkage to care of previously undiagnosed HIV infections require innovative approaches to testing. We sought to determine the feasibility of targeted HIV testing in geographic areas, defined by continuum of care parameters, to identify HIV-infected persons needing linkage or engagement in care. METHODS: Using HIV surveillance data from Washington, DC, we identified census tracts that had an HIV prevalence >1% and were either above (higher risk areas-HRAs) or below (lower risk areas-LRAs) the median for 3 indicators: monitored viral load, proportion of persons out of care (OOC), and never in care. Community-based HIV rapid testing and participant surveys were conducted in the 20 census tracts meeting the criteria. Areas were mapped using ArcGIS, and descriptive and univariate analyses were conducted comparing the areas and participants. RESULTS: Among 1471 persons tested, 28 (1.9%) tested HIV positive; 2.1% in HRAs vs. 1.7% in LRAs (P = 0.57). Higher proportions of men (63.7% vs. 56.7%, P = 0.007) and fewer blacks (91.0% vs. 94.6%, P = 0.008) were tested in LRAs vs. HRAs; no differences were observed in risk behaviors between the areas. Among HIV-positive participants, 54% were new diagnoses (n = 9) or OOC (n = 6), all were Black, 64% were men with a median age of 51 years. CONCLUSIONS: Although significant differences in HIV seropositivity were not observed between testing areas, our approach proved feasible and enabled identification of new diagnoses and OOC HIV-infected persons. This testing paradigm could be adapted in other locales to identify areas for targeted HIV testing and other reengagement efforts.
BACKGROUND: Improved detection and linkage to care of previously undiagnosed HIV infections require innovative approaches to testing. We sought to determine the feasibility of targeted HIV testing in geographic areas, defined by continuum of care parameters, to identify HIV-infectedpersons needing linkage or engagement in care. METHODS: Using HIV surveillance data from Washington, DC, we identified census tracts that had an HIV prevalence >1% and were either above (higher risk areas-HRAs) or below (lower risk areas-LRAs) the median for 3 indicators: monitored viral load, proportion of persons out of care (OOC), and never in care. Community-based HIV rapid testing and participant surveys were conducted in the 20 census tracts meeting the criteria. Areas were mapped using ArcGIS, and descriptive and univariate analyses were conducted comparing the areas and participants. RESULTS: Among 1471 persons tested, 28 (1.9%) tested HIV positive; 2.1% in HRAs vs. 1.7% in LRAs (P = 0.57). Higher proportions of men (63.7% vs. 56.7%, P = 0.007) and fewer blacks (91.0% vs. 94.6%, P = 0.008) were tested in LRAs vs. HRAs; no differences were observed in risk behaviors between the areas. Among HIV-positive participants, 54% were new diagnoses (n = 9) or OOC (n = 6), all were Black, 64% were men with a median age of 51 years. CONCLUSIONS: Although significant differences in HIV seropositivity were not observed between testing areas, our approach proved feasible and enabled identification of new diagnoses and OOC HIV-infectedpersons. This testing paradigm could be adapted in other locales to identify areas for targeted HIV testing and other reengagement efforts.
Authors: Amanda D Castel; Montina Befus; Sarah Willis; Angelique Griffin; Tiffany West; Shannon Hader; Alan E Greenberg Journal: AIDS Date: 2012-01-28 Impact factor: 4.177
Authors: Fabienne Laraque; Heather A Mavronicolas; McKaylee M Robertson; Heidi W Gortakowski; Arpi S Terzian Journal: AIDS Date: 2013-08-24 Impact factor: 4.177
Authors: Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall Journal: Lancet Date: 2010-07-16 Impact factor: 79.321
Authors: Jason A Craw; Lytt I Gardner; Gary Marks; Richard C Rapp; Jeff Bosshart; Wayne A Duffus; Amber Rossman; Susan L Coughlin; DeAnn Gruber; Lauretta A Safford; Jon Overton; Karla Schmitt Journal: J Acquir Immune Defic Syndr Date: 2008-04-15 Impact factor: 3.731
Authors: Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax Journal: PLoS One Date: 2010-06-10 Impact factor: 3.240
Authors: Mindy C Lipsitz; Eddy R Segura; José Luis Castro; Edward Smith; Carlos Medrano; Jesse L Clark; Jordan E Lake; Robinson Cabello Journal: Int J STD AIDS Date: 2013-10-09 Impact factor: 1.359
Authors: Neela D Goswami; Emily J Hecker; Carter Vickery; Marshall A Ahearn; Gary M Cox; David P Holland; Susanna Naggie; Carla Piedrahita; Ann Mosher; Yvonne Torres; Brianna L Norton; Sujit Suchindran; Paul H Park; Debbie Turner; Jason E Stout Journal: PLoS One Date: 2012-10-02 Impact factor: 3.240
Authors: Evan Wood; Thomas Kerr; Brandon D L Marshall; Kathy Li; Ruth Zhang; Robert S Hogg; P Richard Harrigan; Julio S G Montaner Journal: BMJ Date: 2009-04-30
Authors: Gregg S Gonsalves; Forrest W Crawford; Paul D Cleary; Edward H Kaplan; A David Paltiel Journal: Med Decis Making Date: 2017-07-12 Impact factor: 2.583
Authors: Yusuf Ransome; Lorraine T Dean; Natalie D Crawford; David S Metzger; Michael B Blank; Amy S Nunn Journal: J Acquir Immune Defic Syndr Date: 2017-09-01 Impact factor: 3.731
Authors: Allan E Rodriguez; Andrew J Wawrzyniak; Hansel E Tookes; Marcia G Vidal; Manasi Soni; Rita Nwanyanwu; David Goldberg; Rachel Freeman; Kira Villamizar; Maria L Alcaide; Michael A Kolber Journal: AIDS Behav Date: 2019-10
Authors: Sheree R Schwartz; Matthew M Kavanagh; Jeremy Sugarman; Sunil S Solomon; Illiassou M Njindam; Kevin Rebe; Thomas C Quinn; Coumba Toure-Kane; Chris Beyrer; Stefan Baral Journal: J Int AIDS Soc Date: 2017-11 Impact factor: 5.396